Ocugen Inc (NASDAQ:OCGN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - OCGN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - OCGN

  • Market Cap$49.810m
  • SymbolNASDAQ:OCGN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS67577C1053

Company Profile

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).Histogenics Corp is a regenerative medicine company engaged in developing and commercializing products in the musculoskeletal segment of the marketplace.

Latest OCGN news

Currently there for this company. Visit our news hub for other news .